CORRELATION BETWEEN PROLACTIN AND SYMPTOM PROFILE IN ACUTE ADMITTED WOMEN WITH RECURRENT SCHIZOPHRENIA | Zendy

Miroslav Herceg | Zendy; Krešimir Puljić | Zendy; Andrea Jambrošić Sakoman | Zendy; Jelena Sušac | Zendy; Ivana Todorić Laidlaw | Zendy; Dora Herceg | Zendy; Mirna Sisek-Šprem | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

CORRELATION BETWEEN PROLACTIN AND SYMPTOM PROFILE IN ACUTE ADMITTED WOMEN WITH RECURRENT SCHIZOPHRENIA

Author(s) -

Miroslav Herceg,

Krešimir Puljić,

Andrea Jambrošić Sakoman,

Jelena Sušac,

Ivana Todorić Laidlaw,

Dora Herceg,

Mirna Sisek-Šprem

Publication year - 2020

Publication title -

psychiatria danubina

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.394

H-Index - 34

eISSN - 1849-0867

pISSN - 0353-5053

DOI - 10.24869/psyd.2020.367

Subject(s) - neglect , psychological abuse , psychology , feeling , sexual abuse , psychiatry , psychopathology , child abuse , schizophrenia (object oriented programming) , domestic violence , social isolation , physical abuse , clinical psychology , dysfunctional family , borderline personality disorder , medicine , poison control , injury prevention , medical emergency , social psychology

The prevalence of hyperprolactinemia among psychiatric patients receiving antipsychotic medications was estimated to be between 30% and 70%. A review of the literature on prolactin and schizophrenia symptoms suggests that the correlation between them is complex and not limited to the adverse effects of antipsychotics. Relations with specific symptom dimensions have not been found consistently across studies. The association between increased prolactin and recurrent episodes of schizophrenia needs to be replicated in larger samples and in a population of female patients. The aim of this study was to find out whether elevated prolactin is related to specific symptoms or dimensions of schizophrenia, which is a heterogenic entity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research